Oral Infection, Oral Pathology and Salivary Diagnostics of Mpox Disease: Relevance in Dentistry and OMICs Perspectives

• Published in: International journal of molecular sciences Vol. 24; no. 18; p. 14362
• Main Authors: Garcia-Junior, Marcelo Augusto, Andrade, Bruno Silva, Guevara-Vega, Marco, de Melo, Igor Santana, Cunha, Thúlio M, Jardim, Ana Carolina Gomes, Sabino-Silva, Robinson
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01-09-2023; MDPI
• Subjects: Analysis; Body Fluids; Communicable Diseases; Dentistry; Endoplasmic reticulum; Enzyme-linked immunosorbent assay; Epidemics; Genomes; Genomics; Health aspects; Heparan sulfate; Humans; Infection; Infections; Monkeypox; Mpox (monkeypox); multiomics; oral pathology; Pathology, Oral; Proteins; proteomics; Review; RNA; Saliva; Tongue; Zoonoses; United Kingdom > UK; United States > US; Africa; saliva; proteomics; dentistry; oral pathology; virology; monkeypox; multiomics
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms241814362

In this narrative review, we aim to point out the close relationship between mpox virus (MPXV) infection and the role of saliva as a diagnostic tool for mpox, considering the current molecular approach and in the perspective of OMICs application. The MPXV uses the host cell's rough endoplasmic reticulum, ribosomes, and cytoplasmic proteins to replicate its genome and synthesize virions for cellular exit. The presence of oral mucosa lesions associated with mpox infection is one of the first signs of infection; however, current diagnostic tools find it difficult to detect the virus before the rashes begin. MPXV transmission occurs through direct contact with an infected lesion and infected body fluids, including saliva, presenting a potential use of this fluid for diagnostic purposes. Currently available diagnostic tests for MPXV detection are performed either by real-time quantitative PCR (RT-qPCR) or ELISA, which presents several limitations since they are invasive tests. Despite current clinical trials with restricted sample size, MPXV DNA was detected in saliva with a sensitivity of 85%-100%. In this context, the application of transcriptomics, metabolomics, lipidomics, or proteomics analyses coupled with saliva can identify novel disease biomarkers. Thus, it is important to note that the identification and quantification of salivary DNA, RNA, lipid, protein, and metabolite can provide novel non-invasive biomarkers through the use of OMICs platforms aiding in the early detection and diagnosis of MPXV infection. Untargeted mass spectrometry (MS)-based proteomics reveals that some proteins also expressed in saliva were detected with greater expression differences in blood plasma when comparing mpox patients and healthy subjects, suggesting a promising alternative to be applied in screening or diagnostic platforms for mpox salivary diagnostics coupled to OMICs.